NANOTECHNOLOGY-MEDIATED THERAPEUTIC STRATEGIES AGAINST SYNUCLEINOPATHIES IN NEURODEGENERATIVE DISEASE.
- DOI
- 10.1016/j.coche.2021.100673
- Published
- 2021 Mar
- Container
- Current opinion in chemical engineering
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.coche.2021.100673,
title = {NANOTECHNOLOGY-MEDIATED THERAPEUTIC STRATEGIES AGAINST SYNUCLEINOPATHIES IN NEURODEGENERATIVE DISEASE.},
author = {Schlichtmann BW and Hepker M and Palanisamy BN and John M and Anantharam V and Kanthasamy AG and Narasimhan B and Mallapragada SK},
year = {2021},
journal = {Current opinion in chemical engineering},
doi = {10.1016/j.coche.2021.100673},
url = {https://doi.org/10.1016/j.coche.2021.100673}
}RIS
TY - JOUR TI - NANOTECHNOLOGY-MEDIATED THERAPEUTIC STRATEGIES AGAINST SYNUCLEINOPATHIES IN NEURODEGENERATIVE DISEASE. AU - Schlichtmann BW AU - Hepker M AU - Palanisamy BN AU - John M AU - Anantharam V AU - Kanthasamy AG AU - Narasimhan B AU - Mallapragada SK PY - 2021 JO - Current opinion in chemical engineering DO - 10.1016/j.coche.2021.100673 UR - https://doi.org/10.1016/j.coche.2021.100673 ER -
APA
BW, S., M, H., BN, P., M, J., V, A., AG, K., B, N., & SK, M. (2021). NANOTECHNOLOGY-MEDIATED THERAPEUTIC STRATEGIES AGAINST SYNUCLEINOPATHIES IN NEURODEGENERATIVE DISEASE.. Current opinion in chemical engineering. https://doi.org/10.1016/j.coche.2021.100673
Source records
- pubmed · retrieved 2026-09-26T10:36:08.604Z
- europe-pmc · retrieved 2026-09-26T10:36:08.618Z